Article

Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice.

Department of Bone and Joint Surgery, Ehime University Graduate School of Medicine, Ehime, Japan.
Journal of atherosclerosis and thrombosis (Impact Factor: 2.77). 11/2007; 14(5):245-52. DOI: 10.5551/jat.E486
Source: PubMed

ABSTRACT To investigate whether the perinatal and postnatal exposure of mice to bisphenol A (BPA) caused the development of obesity and/or hyperlipidemia.
Pregnant mice were exposed to BPA in drinking water at concentrations of either 1 microg/mL (LD group) or 10 microg/mL (HD group) from gestation day 10 and throughout the lactating period. After weaning, the pups were allowed free access to drinking water containing the appropriate concentrations of BPA. The body weight, adipose tissue weight, and serum lipid levels were measured in the offspring at postnatal day 31.
In females, the mean body weight increased by 13% in the LD group (p<0.05) and 11% in the HD group (p<0.05) compared with the control group. The mean adipose tissue weight increased by 132% in the LD group (p<0.01). The mean total cholesterol level increased by 33% in the LD group (p<0.01) and 17% in the HD group (p<0.05). In males, the mean body weight and mean adipose tissue weight increased by 22% (p<0.01) and 59% (p<0.01), respectively, in the HD group compared with the control group. The mean triacylglycerol level increased by 34% in the LD group (p<0.05).
The continuous exposure of mice to BPA during the perinatal and postnatal periods caused the development of obesity and hyperlipidemia.

0 Followers
 · 
106 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bisphenol A (BPA) and triclosan (TCS) were determined in urine of Belgian overweight and obese (n = 151) and lean (n = 43) individuals. After the first urine collection (0 M), obese patients started a diet program or have undergone bariatric surgery. Hereafter, three additional urine samples from obese patients were collected after 3 (3M), 6 (6M) and 12 (12 M) months. Both compounds were detected in N99% of the samples. BPA had median concentrations of 1.7 and 1.2 ng/mL in obese and lean groups, respectively, while TCS had median concentrations of 1.5 and 0.9 ng/mL in the obese and lean groups, respectively. The obese group had higher urinary concentrations (ng/mL) of BPA (p b 0.5),while no significant differences were found for TCS between the obese and lean groups. No time trends between the different collection moments were observed. The BPA concentrations in the obese group were negatively associated with age, while no gender difference or relationship with body mass index was observed. For TCS, no relationships with gender, BMI, or age were found. The temporal variability of BPA and TCS was assessed with calculation of the intra class correlation coefficient, Spearman rank correlation coefficients, and surrogate category analysis. We observed evidence that single spot urine samples might be predictive of exposure over a longer period of time. Dietary intakes of BPA and TCS did not differ significantly among the time points considered after obese individuals started losing weight (6 and 12 months). Multiple linear regression analyses after adjusting for age and weight loss revealed negative associations between urinary TCS and serum FT4 in the 0M and 3M female obese individuals and positive associations between urinary BPA and serum TSH in the lean group.
    Environment international 03/2015; 76(2015):98-105. · 5.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bisphenol A (BPA) is an environmental endocrine disrupter. Excess exposure to BPA may increase susceptibility to many metabolic disorders, but it is unclear whether BPA exposure has any adverse effects on the development of atherosclerosis. To determine whether there are such effects, we investigated the response of Watanabe heritable hyperlipidemic (WHHL) rabbits to 400-µg/kg BPA per day, administered orally by gavage, over the course of 12 weeks and compared aortic and coronary atherosclerosis in these rabbits to the vehicle group using histological and morphometric methods. In addition, serum BPA, cytokines levels and plasma lipids as well as pathologic changes in liver, adipose and heart were analyzed. Moreover, we treated human umbilical cord vein endothelial cells (HUVECs) and rabbit aortic smooth muscle cells (SMCs) with different doses of BPA to investigate the underlying molecular mechanisms involved in BPA action(s). BPA treatment did not change the plasma lipids and body weights of the WHHL rabbits; however, the gross atherosclerotic lesion area in the aortic arch was increased by 57% compared to the vehicle group. Histological and immunohistochemical analyses revealed marked increases in advanced lesions (37%) accompanied by smooth muscle cells (60%) but no significant changes in the numbers of macrophages. With regard to coronary atherosclerosis, incidents of coronary stenosis increased by 11% and smooth muscle cells increased by 73% compared to the vehicle group. Furthermore, BPA-treated WHHL rabbits showed increased adipose accumulation and hepatic and myocardial injuries accompanied by up-regulation of endoplasmic reticulum (ER) stress and inflammatory and lipid metabolism markers in livers. Treatment with BPA also induced the expression of ER stress and inflammation related genes in cultured HUVECs. These results demonstrate for the first time that BPA exposure may increase susceptibility to atherosclerosis in WHHL rabbits.
    PLoS ONE 10/2014; 9(10):e110977. DOI:10.1371/journal.pone.0110977 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous experimental, clinical and epidemiological studies show that exposure to environmental contaminants may disrupt endocrine and metabolic functions of our organism. This would contribute to the development of obesity and associated metabolic disorders such as nonalcoholic hepatic steatosis, characterized by an excessive accumulation of triglycerides in the liver, which may lead to more severe forms of NAFLD (Non-Alcoholic Fatty Liver Diseases) such as inflammation, fibrosis, cirrhosis and hepatocellular carcinoma. In this work, in vivo studies have highlighted that chronic exposure to the xenoestrogen BPA, widely used in plastic food packaging industry, affects hepatic energy metabolism. It promotes the storage of triglycerides and cholesterol ester in the liver, in association with the induction of the hepatic transcriptome, more particularly of genes involved in lipid, carbohydrates and cholesterol synthesis. These effects, which could contribute to promote hepatic steatosis, follow an inverted U shape non-monotonic dose-response curve and were observed below the reference dose in regulatory toxicology: the tolerable daily intake. These results strengthen the idea that BPA act as a metabolic disruptor, particularly at low doses. Nuclear receptors are targets through which metabolic disruptors may influence gene expression. Recent studies showed that the nuclear receptors CAR (Constitutive Receptor Androstane) and PXR (Pregnane X Receptor), initially identified as key receptors of the detoxification process, are also involved in the regulation of energy metabolism. We identified the gene coding for adiponutrin/PNPLA3 (Patatin-like phospholipase domain-containing) as a new target of these xenosensors. We have shown with transgenic animal models and with hepatocyte cell lines that the CAR and PXR receptors regulate the Pnpla3 gene expression. This protein has a central role in hepatic lipid metabolism through its dual transacylase and lipase activity. In human, a variant of the Pnpla3 (SNP I148M) gene has been identified as a new marker of hepatic steatosis and is associated with an increased risk of NAFLD. Since the xenosensors CAR and PXR are known to be activated by many drugs and environmental pollutants, our results highlight the risk of a development of hepatic steatosis after their activation. Taken together, these results highlight the risk of metabolic disruptions after exposure to various environmental contaminants such as endocrine disruptors and CAR activators. RÉSUMÉ De nombreuses études expérimentales, cliniques et épidémiologiques récentes montrent que l’exposition à des contaminants de notre environnement pourrait perturber les fonctions métaboliques et endocriniennes des organismes. Ceci contribuerait au développement de l'obésité et des pathologies métaboliques associées telles que la stéatose hépatique non alcoolique, caractérisée par une accumulation massive de triglycérides dans le foie, et qui est susceptible d’évoluer vers des pathologies plus sévères (inflammation, fibrose, cirrhose, carcinome hépatocellulaire), regroupées sous le terme de NAFLD (Non- Alcoholic Fatty Liver Diseases). Nos études réalisées chez le rongeur nous ont permis de mettre en évidence un impact sur le métabolisme hépatique suite à une exposition chronique au Bisphénol A (BPA), un contaminant oestrogéno-mimétique largement exploité dans l’industrie des emballages alimentaires plastiques. Il modifie l’expression des gènes impliqués dans la synthèse des lipides, des glucides et du cholestérol et favorise l’accumulation de triglycérides et d’esters de cholestérol au niveau hépatique. Ces effets, qui pourraient contribuer à l’émergence de la stéatose hépatique, ont été observés en deçà de la dose de référence en toxicologie réglementaire (la dose journalière admissible) et suivent une courbe dose-réponse non monotone en U inversé. Ces résultats renforcent l’idée que le BPA est un perturbateur métabolique, surtout lors d’expositions à faibles doses. Les récepteurs nucléaires représentent des cibles potentielles des perturbateurs métaboliques. Plusieurs études récentes montrent que les récepteurs nucléaires CAR (Constitutive Androstane Receptor) et PXR (Pregnane X Receptor), initialement identifiés comme des récepteurs clés du système de détoxification, sont également impliqués dans la régulation du métabolisme énergétique. Nos travaux ont permis d’identifier une nouvelle cible de ces xénosenseurs : le gène codant pour l’adiponutrine/PNPLA3 (Patatinlike phospholipase domain-containing). Nous avons montré, in vivo et sur des lignées d'hépatocytes en culture, que les récepteurs CAR et PXR régulent l’expression du gène Pnpla3. Cette protéine présente une activité à la fois transacylase et lipase qui lui confère un rôle central dans la régulation du métabolisme lipidique hépatique. Chez l’Homme, un variant du gène Pnpla3 (SNP I148M) a été identifié comme un nouveau marqueur de la stéatose hépatique et est associé à un risque accru de développement de NAFLD. Les xénosenseurs CAR et PXR étant activés par de nombreux médicaments et polluants environnementaux, nos résultats mettent en exergue le risque de développement de stéatoses hépatiques suite à leur activation. L’ensemble de ces résultats renforce l’idée d’un risque de développement de pathologies métaboliques suite à l’exposition à différents contaminants environnementaux, qu’il s’agisse de perturbateurs endocriniens de type métaboliques ou d’activateurs des xénosenseurs CAR et PXR.
    12/2012, Degree: PhD, Supervisor: Dr Laila MSELLI-LAKHAL ; Dr Thierry PINEAU

Preview

Download
0 Downloads